wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24200497-0B8716C6-40C1-4163-B6C5-85342EA7B037
Q24200497-0B8716C6-40C1-4163-B6C5-85342EA7B037
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24200497-0B8716C6-40C1-4163-B6C5-85342EA7B037
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
P2860
Q24200497-0B8716C6-40C1-4163-B6C5-85342EA7B037
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24200497-0B8716C6-40C1-4163-B6C5-85342EA7B037
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
963b88671da5bf7b718c0fd1cf1d1dae5a4b794c
P2860
Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.